Literature DB >> 31113763

Standard versus ultrasound-guided radial and femoral access in coronary angiography and intervention (SURF): a randomised controlled trial.

Phong Nguyen1, Angela Makris, Annemarie Hennessy, Sumedh Jayanti, Alexandra Wang, Kevin Park, Vanessa Chen, Tram Nguyen, Sidney Lo, Wei Xuan, Melissa Leung, Craig Juergens.   

Abstract

AIMS: This study aimed to compare outcomes in unselected patients undergoing cardiac catheterisation via transradial versus transfemoral access and standard versus ultrasound-guided arterial access. METHODS AND
RESULTS: This was a prospective, randomised (radial vs. femoral and standard vs. ultrasound), 2x2 factorial trial of 1,388 patients undergoing coronary angiography and percutaneous coronary intervention. The primary outcome was a composite of ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) major bleeding, MACE (death, stroke, myocardial infarction or urgent target lesion revascularisation) and vascular complications at 30 days. Transradial access reduced the primary outcome (RR 0.37, 95% CI: 0.17-0.81; p=0.013), mostly driven by ACUITY major bleeding (RR 0.343, 95% CI: 0.123-0.959; p=0.041) when compared with the transfemoral approach. There was no difference in the primary outcome between standard and ultrasound guidance (p=0.76). Ultrasound guidance, however, reduced mean access time (93 sec vs. 111 sec; p=0.009), attempts (1.47 vs. 1.9; p<0.0001), difficult accesses (4.5% vs. 9.2%; p=0.0007), venepuncture (4.1% vs. 9.2%; p<0.0001) and improved first-pass success (73% vs. 59.7%; p<0.0001).
CONCLUSIONS: Transradial access significantly reduced the composite outcome compared to transfemoral access. Ultrasound guidance did not reduce the primary outcome compared to the standard technique, but significantly improved the efficiency and overall success rate of arterial access.

Entities:  

Mesh:

Year:  2019        PMID: 31113763     DOI: 10.4244/EIJ-D-19-00336

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial.

Authors:  Sanjit S Jolly; Sulaiman AlRashidi; Marc-André d'Entremont; Omar Alansari; Bradley Brochu; Laura Heenan; Elizabeth Skuriat; Jessica Tyrwhitt; Michael Raco; Michael Tsang; Nicholas Valettas; James L Velianou; Tej Sheth; Matthew Sibbald; Shamir R Mehta; Natalia Pinilla-Echeverri; Jon David Schwalm; Madhu K Natarajan; Andrew Kelly; Elie Akl; Sarah Tawadros; Mercedes Camargo; Walaa Faidi; John Bauer; Rachel Moxham; James Nkurunziza; Gustavo Dutra; Jose Winter
Journal:  JAMA Cardiol       Date:  2022-09-18       Impact factor: 30.154

Review 2.  Ultrasound guidance for arterial (other than femoral) catheterisation in adults.

Authors:  Ronald Lg Flumignan; Virginia Fm Trevisani; Renato D Lopes; Jose Cc Baptista-Silva; Carolina Dq Flumignan; Luis Cu Nakano
Journal:  Cochrane Database Syst Rev       Date:  2021-10-12

3.  Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Sabato Sorrentino; Phong Nguyen; Nadia Salerno; Alberto Polimeni; Jolanda Sabatino; Angela Makris; Annemarie Hennessy; Gennaro Giustino; Carmen Spaccarotella; Annalisa Mongiardo; Salvatore De Rosa; Craig Juergens; Ciro Indolfi
Journal:  J Clin Med       Date:  2020-03-03       Impact factor: 4.241

4.  Clinical Outcomes Following Hemodynamic Parameter or Intravascular Imaging-Guided Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents: An Updated Systematic Review and Bayesian Network Meta-Analysis of 28 Randomized Trials and 11,860 Patients.

Authors:  Meng-Jin Hu; Jiang-Shan Tan; Lu Yin; Yan-Yan Zhao; Xiao-Jin Gao; Jin-Gang Yang; Yue-Jin Yang
Journal:  Front Cardiovasc Med       Date:  2022-06-03

Review 5.  Radial Access for Coronary Angiography Carries Fewer Complications Compared with Femoral Access: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Gani Bajraktari; Zarife Rexhaj; Shpend Elezi; Fjolla Zhubi-Bakija; Artan Bajraktari; Ibadete Bytyçi; Arlind Batalli; Michael Y Henein
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.